Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A health care worker holds a COVID-19 vaccine at the Research Centers of America (RCA) in Hollywood, Florida on Aug. 13. Photo: Chandan Khanna/AFP via Getty Images

51% of U.S. adults would "definitely or probably" get a coronavirus vaccine if the treatment were available today, while 49% would not, according to a Pew survey published Thursday.

Why it matters: All major political and demographic groups said they are less likely to get a COVID-19 vaccine since May, Pew finds, although Republicans and Black adults are least likely.

By the numbers: Intent to get a vaccine fell from 72% in May to 51%.

  • 58% of Democrats said they would probably or definitely be vaccinated, while 44% of Republicans said they would — a 14-percentage point divide.
  • 32% of Black adults said they would definitely or probably get a vaccine, compared to 52% of White adults, 56% of Hispanics and 72% of Asian Americans.

Between the lines: Worries about side effects and uncertainty as to how effective a vaccine would be were commonly cited in the survey as reasons for wanting to avoid a vaccine if one were available.

  • Of the 49% Americans who said they would not get vaccinated, 76% attributed that opinion to side effects.

The big picture: There are eight potential vaccines in late-stage trials right now, per Axios' Sam Baker, and the first could reach FDA review as early as October or November.

The bottom line: A coronavirus vaccine is needed to reinforce herd immunity, especially without a significant loss of life.

Methodology: Survey of 10,093 respondents from the Pew American Trends Panel conducted from Sept. 8 to Sept. 13. MOE ± 1.6 percentage points.

Go deeper

Dec 25, 2020 - World

Chile becomes first South American country to start COVID vaccination

Nurse receiving the Pfizer-BioNTech vaccine in Santiago, Chile. Photo: David Lillo/Ministerio de Salud de Chile via Getty Images

Chile became the first country in South America to begin coronavirus vaccinations on Thursday after receiving its first 10,000 Pfizer-BioNTech doses, Reuters reports.

The big picture: The country bought 10 million doses from Pfizer-BioNTech and is expected to receive 240,000 doses in January, per Reuters.

UN Security Council meeting on Israel-Gaza as fighting enters 7th day

Smoke billows from a fire following Israeli airstrikes on multiple targets in Gaza on May 16. Photo: Mohammed Abed/AFP via Getty Images

The United Nations Security Council was preparing to meet Sunday, as the aerial bombardment between Israel and Hamas between entered a seventh day.

The latest: Four Palestinians died in airstrikes early Sunday, as Israeli forces bombed the home of Gaza's Hamas chief, Yehya al-Sinwar, per Reuters.